Ascendiant Capital Maintains Buy on PAVmed, Raises Price Target to $57
PAVmed, Inc.
PAVmed, Inc. PAVM | 0.00 |
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:
PAVM) with a Buy and raises the price target from $56 to $57.
Ascendiant Capital Maintains Buy on PAVmed, Raises Price Target to $57
PAVmed, Inc. PAVM | 0.00 |